Quantcast

Latest Rofecoxib Stories

2010-12-01 08:18:22

(Ivanhoe Newswire) -- Nonmelanoma skin cancers are some of the most commonly diagnosed in the U.S. A new study found a possible preventative treatment in the nonsteroidal, anti-inflammatory drug Celecoxib. Celecoxib is typically used to inhibit the enzyme cyclooxygenase 2, which has been associated with the onset of UV ray-caused nonmelanoma skin cancers.  Since sunscreen has only shown mediocre results in protecting reducing these cancers, researchers at the University of Alabama at...

2010-09-14 01:13:35

A research team from the University of California, Davis and Peking University, China, has discovered a novel mechanism as to why the long-term, high-dosage use of the well-known arthritis pain medication, Vioxx, led to heart attacks and strokes. Their groundbreaking research may pave the way for a safer drug for millions of arthritis patients who suffer acute and chronic pain. Using metabolomic profiling to analyze murine (rodent) plasma, the scientists discovered that Vioxx causes a...

710cd4b16f34a75d6e5c40ddc284068f1
2010-08-20 07:59:25

Researchers, in a new study, found that common painkillers that have been linked to risks of heart attack may also increase the risk of stroke.Nearly 38,000 Taiwanese adults who suffered a stroke over one year, researchers found the use of a non-steroidal anti-inflammatory drug (NSAID) in the month prior to the stroke may have elevated that risk.Results of the study were reported in the medical journal Stroke. Researchers said the increases linked to individual NSAID use were generally...

b0957c64f088eedca4cb437867702267
2010-07-15 06:05:00

A panel of U.S. Food and Drug Administration advisers voted Wednesday to allow GlaxoSmithKline's diabetes drug Avandia to remain on the market, but with new restrictions due to the risky cardiovascular side effects of the controversial pill. The panel of experts voted 20-12 to retain availability of Avandia to diabetics, although 10 panelists called for limiting who can receive and prescribe the once-blockbuster medication. British drugmaker Glaxo has been hit with thousands of lawsuits from...

2010-04-10 18:29:00

LOS ANGELES, April 10 /PRNewswire/ -- In selecting U.S. District Judge James V. Selna to hear more than 100 federal lawsuits filed around the country against Toyota, a federal judicial panel also granted a formal request by the Lanier Law Firm to rename the litigation and expand its scope. "We're thrilled," says attorney Mark Lanier, who was recently named one of the decade's most influential lawyers by the National Law Journal. "This is far from merely a mechanical problem. We...

2010-03-03 12:14:00

HOUSTON, March 3 /PRNewswire/ -- The Lanier Law Firm is announcing a lawsuit filed today in Harris County state district court by the family of a Houston woman who was injured in a crash while driving a Toyota Camry with a defective acceleration control system. Attorney Mark Lanier, founder of The Lanier Law Firm, and Tammy Tran of Houston's The Tammy Tran Law Firm are representing Anna Pham and her mother Natalie Pham in their claims against Toyota Motor Corp. and Auto Spot, the...

2010-02-23 14:26:00

MONTGOMERY, Ala., Feb. 23 /PRNewswire/ -- Beasley Allen attorney Graham Esdale is in Washington, DC this week with three adult children of the firm's deceased client Barbara Schwarz. Esdale and clients, Margie Louise Meibergen, Sharon L. Brandt and Julie Brandt Mayfield, will be attending the congressional hearings this week and are willing to speak to the media. The group appeared on the CBS Early Show Tuesday morning and later on CNN. The family of Mrs. Schwarz plans to speak with...

a12dc1895ac91f38bb53069d7939348c1
2010-01-06 07:30:00

The Food and Drug Administration fell short with drug approvals in 2009 and drug warnings were lacking, even as the FDA's new leadership adopted a tougher attitude on safety, according to the Associated Press. According to investment research group Washington Analysis, the FDA approved 26 new prescriptions last year, up slightly from the year before. Thirty-one new or updated warning labels were added to drugs already on the market. That number is down from 56 warnings the previous year,...

2009-12-01 18:20:00

NEW YORK, Dec. 1 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies http://www.reportlinker.com/p0166813/Direct-to-Consumer-DTC-Advertising-in-Pharmaceuticals---Current-and-Future-Market-Outlook-Regulatory-Landscape-and-Case-Studies.html Summary The author has released its latest research, "Direct to...

2009-11-30 16:22:23

Head to Head: Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? On bmj.com today two experts debate whether the conflict of interest is unacceptable when drug companies carry out clinical trials on their own medicines. Their views come as new guidance on the standards required for communicating company sponsored medical research is published. Vincent Lawton, a healthcare consultant and non-executive director at the Medicines and Healthcare...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.